The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Prevenar



Wyeth Lederle Vaccines S.A.EU/1/00/167/4-7

Main Information

Trade NamePrevenar
Active SubstancesPneumococcal polysaccharide type 23 (23f)
Pneumococcal type 6b
Pneumococcal polysaccharide type 19 (19f)
Pneumococcal polysaccharide type 4 (4)
Pneumococcal polysaccharide type 9v
Pneumococcal polysaccharide type 56 (18c)
Pneumococcal polysaccharide type 14 (14)
Dosage FormSuspension for injection
Licence HolderWyeth Lederle Vaccines S.A.
Licence NumberEU/1/00/167/4-7

Group Information

ATC CodeJ07AL Pneumococcal vaccines

Status

License statusAuthorised
Licence Issued02/02/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back